The share allocation results for MICOT PHARMA-B (02335) have been announced.

The company's global offering consists of approximately 58.0544 million H shares. The Hong Kong public offering portion accounts for 10% of the total, with the international offering making up the remaining 90%.

The final offer price has been set at HK$18.2 per share. The net proceeds from the global offering are expected to be approximately HK$989 million.

Each board lot comprises 200 shares. The H shares are scheduled to commence trading on the Stock Exchange at 9:00 a.m. on Wednesday, June 24, 2026.

The Hong Kong public offering was oversubscribed by approximately 1,181.46 times. The international offering was oversubscribed by about 2.52 times.